|
|
Application value of liver fibrosis indexes combined with AFP and GGT in the diagnosis of liver diseases |
LI Zhangyong1 LIN Yingbiao1▲ XIA Chuan1 LI Gangyong2 |
1.Clinical Laboratory, Chenzhou NO.1 People′s Hospital, Hu′nan Province, Chenzhou 423000, China;
2.Hepatology Department, Chenzhou NO.1 People′s Hospital, Hu′nan Province, Chenzhou 423000, China |
|
|
Abstract Objectives To discussion of liver fibrosis index [Ⅲ type collagen (PCⅢ), collagen type Ⅳ before (Ⅳ-C), laminin (LN), hyaluronic acid (HA), gansu cholic acid (CG)], alpha fetal protein (AFP) and γ- glutamyl transpeptidase (GGT) in the diagnosis of liver disease. Methods From July 2017 to June 2018, in Chenzhou NO.1 People′s Hospital of Hunan Province ("our hospital" for short), 90 cases of chronic HBV (carry HBV group), 66 patients with cirrhosis of the liver (cirrhosis group) and 52 patients with hepatitis B related liver cancer (HBV-related liver cancer group), 60 cases (healthy control group) health physical examination were selected from the same period. The liver fibrosis indexes PCⅢ, Ⅳ-C, LN and HA, CG and AFP and GGT of each groups were detected by automatic chemiluminescence analyzer and biochemical analyzer respectively. Results PCⅢ, Ⅳ-C, HA, CG and AFP in the three groups were all higher than those in the healthy control group, and the difference were highly statistically significant (P < 0.01). LN and GGT of liver cirrhosis group and HBV-related liver cancer group were higher than that of healthy control group, and the difference were statistically significant (P < 0.05). There was no significant difference in LN and GGT between the chronic HBV carrier group and the healthy control group (P > 0.05). HA, CG and AFP were compared among the groups, and the difference were statistically significant (P < 0.05). Conclusion Liver fibrosis indicators PCⅢ, Ⅳ-C, LN, HA, CG, GGT and AFP have great application value in the diagnosis of liver disease, and have important value in guiding clinical treatment.
|
|
|
|
|
[1] 王微,虞留明,朱学源.甘胆酸检测在肝胆疾病临床诊断中的意义[J].中华临床医师杂志:电子版,2014,8(15):2861-2865.
[2] 刘风华,王李洁,周运恒,等.探索15项生化指标联合检测对肝脏恶性肿瘤首次治疗后的应用价值[J].检验医学,2017,32(5):353-360.
[3] 陈俊,王利健,汤晓君.肿瘤标志物和肝纤维化指标检测在肝病诊断中的价值[J].中国卫生检验杂志,2016,26(4):516-518.
[4] 周新玲,刘焕星.缺氧诱导因子-1α和血管内皮生长因子对肝硬化的研究进展[J].泰山医学院学报,2014,35(3):238-240.
[5] 宋向东,刘争,赵华,等.肝脾联合切除治疗肝癌伴肝硬化功能亢进临床研究[J].中国卫生标准管理,2016,7(15):40-41.
[6] 陆兴热,陈凤羽,刘孝文,等.肝病患者AFP、TP、ALB、SOD检测的临床价值[J].分子诊断与治疗杂志,2017,9(1):37-40.
[7] 丁以琨.术后预防性肝动脉化疗栓塞对肝细胞癌患者生存的影响及预后相关因素分析[J].安徽医科大学,2014, 23(4):299-232.
[8] 李凌.慢性肝病患者血清甲胎蛋白等指标检测的临床分析[J].检验医学与临床,2013,10(1):17-18.
[9] 柳锡琴.AFP、GGT和ADA在肝癌诊断中的临床意义[J].临床医学研究与实践,2017,2(35):18-19.
[10] 陆梦丽,吕礼应.均相酶免疫法检测甘胆酸的临床应用研究[J].中国卫生检验杂志,2017,27(17):2536-2538.
[11] 张有涛,宋艳辉,黄恵芳,等.甘胆酸检测的临床实践及与其他肝功能指标的比较[J].国际检验医学杂志,2017, 38(5):680-682.
[12] Zhu CB,Wang CX,Zhang X,et al. Serum sHLA-G levels:a useful indicator in distinguishing colorectal cancer from benign colorectal diseases [J]. Int J Cancer,2011, 12(3):617-622.
[13] 魏梅娟,魏开鹏,张小曼,等.血清肝纤维化指标与肝纤维化病理改变的相关性研究[J].中华实验和临床感染病杂志:电子版,2013,6(7):860-864.
[14] 赵红,吕蓓,黄绍萍,等.Fibroscan联合血清肝纤维化标志物诊断早期肝硬化的研究[J].胃肠病学和肝病学杂志,2015,13(4):447-451.
[15] 王立军,肖晋,胡邦浩.探讨阿德福韦酯联合双虎肝颗粒抗肝纤维化指标肝纤四项复常率[J].当代医学,2012, 18(7):270-271.
[16] 陈俊,王利健,汤晓君.肿瘤标志物和肝纤维化指标检测在肝病诊断中的价值[J].中国卫生检验杂志,2016, 26(4):516-518.
[17] 张卫军,王瑞霞.肝硬化应用生化检验项目的价值与检验结果分析[J].中国现代医生,2017,55((11)):91-93.
[18] 陈学远,李雅倩,冯哲敏,等.特发性肺纤维化患者血清透明质酸、层黏连蛋白的变化及意义[J].中国医药导报,2017,14(16):44-46.
[19] El-Shabrawi MH,Zein EI Abedin MY,Omar N,et al. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major [J]. Arab. J Gastroenterol,2012,13(2):45-48.
[20] 吴桐,常虹,石松利,等.蒙古扁桃石油醚提取物对四氯化碳致大鼠肝纤维化的保护作用[J].中华中医药学刊,2017,35(3):595-598.
[21] 曾小辉,沙卫红,杨兵,等.血清肝纤维化与肝功能及肝肿瘤指标的关系[J].临床医学工程,2010,17(7):41-42.
[22] 李嘉妍,宋金云,王建芳,等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志,2017,33(7):1291-1295.
[23] 邓伟伟,朱文明,易超,等.不同AFP水平下血清IL-1与肝癌根治术后早期复发和预后的关系[J].临床肝胆病杂志,2018,34(2):298-302.
[24] 周艳.熊去氧胆酸治疗活动性代偿期乙肝肝硬化影响GGT的临床观察[J].中国医药导报,2009,6(20):51-52.
[25] 陈国梁,项美姣,张家敏,等.四种常见血清肝酶在乙型肝炎相关性肝癌中的表达和意义[J].中华医院感染学杂志,2017,27(3):525-528. |
|
|
|